Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Int J Rheum Dis ; 27(1): e15029, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38287557

ABSTRACT

AIM: The objective of this study was to assess the gastrointestinal side (GI) effects of oral methotrexate (MTX) in Japanese adult patients with rheumatoid arthritis (RA). METHODS: In this single-center retrospective study, 112 Japanese adult patients (over 18 years old) with RA were examined by Methotrexate Intolerance and Severity assessment in Adults (MISA) questionnaire. RESULTS: Forty-five (40.2%) of patients were MTX intolerant (MISA score ≥1). Twelve patients (11.2%) were moderate-to-severe MTX intolerant (MISA cross-product score ≥4). The most common GI side effects of MTX were gastric discomfort (26.8%), followed by loss of appetite or dysgeusia (14.3%), fatigue and lethargy (12.5%), and nausea (10.7%). CONCLUSIONS: Japanese adult patients with RA showed a high prevalence of MTX intolerance even in low-dose oral MTX. The MISA questionnaire was practical for finding patients with MTX intolerance.


Subject(s)
Antirheumatic Agents , Arthritis, Rheumatoid , Adult , Humans , Adolescent , Methotrexate/therapeutic use , Antirheumatic Agents/therapeutic use , Retrospective Studies , Japan , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/chemically induced , Treatment Outcome
2.
Biochem Biophys Res Commun ; 489(3): 305-311, 2017 07 29.
Article in English | MEDLINE | ID: mdl-28559141

ABSTRACT

BACKGROUND: Methods for the artificial three-dimensional (3D) culture of mouse and human small-intestinal and large-intestinal stem cells have been established with CD24+ or Paneth cell niches. In contrast, no studies have established stable 3D culture for rat colon stem cells. In this study, we established an advanced method for efficient rat colonic stem cell culture. METHODS: Using various tissue homogenates, we investigated the colonic organoid forming capacity under the TMDU protocol immediately adjacent to Ootani's 3D culture assembly in the same culture dish. Next, we examined whether the supernatant from the colon could be replaced by a colon homogenate. Finally, we identified the bioactive substances that were indispensable for efficient organoid culture using protein purification by three-step column chromatography and proteomic analysis with a quantitative nanoflow liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: By combining Ootani's method with the TMDU protocol, we established a refined culture method for Lewis rat colon organoids, which we refer to as the modified TMDU protocol. Furthermore, we confirmed that PGE2 and galection-4 promoted rat colonic organoid formation. CONCLUSIONS: We established efficient rat colonic stem cell cultures in vitro. This success will contribute to the study of rat intestinal-disease models.


Subject(s)
Colon/cytology , Organ Culture Techniques/methods , Organoids/cytology , Organoids/growth & development , Animals , Cells, Cultured , Colon/growth & development , Rats , Stem Cells/cytology
4.
Mod Rheumatol ; 26(3): 391-7, 2016.
Article in English | MEDLINE | ID: mdl-26375328

ABSTRACT

OBJECTIVES: In immunoglobulin (Ig) G4-related disease (IgG4-RD), the mechanism of chronic inflammation and predictive factors for drug-free remission is still unclear. To examine the issues, we focused on tuberculosis, a chronic infection, and on the role of interleukin (IL)-32. METHODS: We examined the positive rate of QuantiFERON TB-2G (QFT-2G) in 126 patients with IgG4-RD, and compared with the rate in the general population. Furthermore, specimens of submandibular glands from the maintenance treatment group and drug-free group of IgG4-RD and specimens of small salivary glands from primary Sjögren's syndrome (SS) were stained with anti-IL-32 antibody and anti-protease-activated receptor 2 antibody, and the number of positive cells was compared between these groups. RESULTS: The positive rate of QFT-2G was 19.8% in IgG4-RD patients, which is higher than in the general population. The expression of IL-32 and PAR2 in the submandibular glands of the maintenance treatment group of IgG4-RD was significantly greater than that of the drug-free remission group and SS patients. CONCLUSIONS: This study indicates the possibility that IL-32 is associated with chronic inflammation and that it can be a predictive factor for drug-free remission in IgG4-RD.


Subject(s)
Immunoglobulin G/immunology , Interleukins/metabolism , Salivary Glands/metabolism , Sjogren's Syndrome/metabolism , Tuberculosis/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , Female , Humans , Inflammation/immunology , Inflammation/metabolism , Male , Middle Aged , Receptor, PAR-2/metabolism , Salivary Glands/immunology , Sjogren's Syndrome/immunology , Tuberculosis/immunology
5.
Mod Rheumatol ; 26(2): 281-5, 2016.
Article in English | MEDLINE | ID: mdl-24289198

ABSTRACT

We report the case of a 76-year-old man diagnosed with angioimmunoblastic T-cell lymphoma (AITL) with high serum vascular endothelial growth factor (VEGF) preceded by Remitting seronegative symmetrical synovitis with pitting edema syndrome. He suffered respiratory discomfort caused by large amounts of pleural effusion. Interestingly, changes in serum VEGF measured over time were similar to changes in pleural effusion. Whether VEGF is related to the pathological condition of AITL is a very important question.


Subject(s)
Edema/complications , Immunoblastic Lymphadenopathy/complications , Lymphoma, T-Cell/complications , Synovitis/complications , Vascular Endothelial Growth Factor A/blood , Aged , Disease Progression , Edema/blood , Humans , Immunoblastic Lymphadenopathy/blood , Lymphoma, T-Cell/blood , Male , Synovitis/blood
6.
Ann Hematol ; 95(1): 35-40, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26377996

ABSTRACT

Both multicentric Castleman's disease (MCD) and immunoglobulin (Ig)G4-related disease (IgG4-RD) are systemic diseases, presenting with hypergammaglobulinemia and elevated serum levels of IgG4. However, with regard to histopathological findings, MCD shows atrophic germinal centers. On the other hand, expanded germinal centers are detected in IgG4-RD. We extracted germinal centers from specimens of each disorder by microdissection and analyzed the expression of mRNAs by real-time polymerase chain reaction to clarify the mechanisms underlying atrophied germinal centers in MCD. This analysis disclosed loss of interleukin (IL)-21 and B cell lymphoma (Bcl)-6 in the germinal centers of MCD. Loss of IL-21 is considered to be involved in the disappearance of Bcl-6 and leads to atrophied germinal centers in MCD.


Subject(s)
Castleman Disease/diagnosis , Castleman Disease/metabolism , Germinal Center/metabolism , Germinal Center/pathology , Interleukins/biosynthesis , Interleukins/deficiency , Adult , Aged , Atrophy/metabolism , Atrophy/pathology , Female , Humans , Male , Middle Aged
10.
PLoS One ; 10(9): e0137801, 2015.
Article in English | MEDLINE | ID: mdl-26375822

ABSTRACT

BACKGROUND: The common disease-common variant hypothesis is insufficient to explain the complexities of Crohn's disease (CD) genetics; therefore, rare variants are expected to be important in the disease. We explored rare variants associated with susceptibility to CD in Japanese individuals by personal genomic analysis. METHODS: Two-step analyses were performed. The first step was a trio analysis with whole-exome sequence (WES) analysis and the second was a follow-up case-control association study. The WES analysis pipeline comprised Burrows-Wheeler Aligner, Picard, Genome Analysis Toolkit, and SAMTOOLS. Single nucleotide variants (SNVs)/indels were annotated and filtered by using programs implemented in ANNOVAR in combination with identity-by-descent (IBD), subsequently were subjected to the linkage based, and de novo based strategies. Finally, we conducted an association study that included 176 unrelated subjects with CD and 358 healthy control subjects. RESULTS: In family members, 234,067-297,523 SNVs/indels were detected and they were educed to 106-146 by annotation based filtering. Fifty-four CD variants common to both individuals of the affected sib pair were identified. The linkage based strategy detected five candidate variants whereas the de novo based strategy identified no variants. Consequently, five candidates were analyzed in the case-control association study. CD showed a significant association with one variant in exon 4 of IL23R, G149R [rs76418789, P = 3.9E-5, odds ratio (OR) 0.21, 95% confidence interval (CI) 0.09-0.47 for the dominant model (AA + AG versus GG), and P = 7.3E-5, OR 0.21, 95% CI 0.10-0.48 for AG versus GG, and P = 7.2E-5, OR 0.23, 95% CI 0.10-0.50 for the allele model]. CONCLUSIONS: The present study, using personal genomics analysis of a small CD pedigree, is the first to show that the low-frequency non-synonymous variant of IL23R, rs76418789, protects against CD development in Japanese subjects.


Subject(s)
Crohn Disease/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide/genetics , Precision Medicine , Receptors, Interleukin/genetics , Adult , Aged , Case-Control Studies , Crohn Disease/pathology , Female , Genomics , Humans , Male , Middle Aged , Pedigree , Young Adult
11.
J Gastroenterol ; 50(9): 962-74, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25680886

ABSTRACT

BACKGROUND: The role of mesenchymal stem/stromal cells (MSCs) in tumorigenesis remains controversial. This study aimed to determine whether heterotypic interactions between MSCs and colon cancer cells can supply contextual signals towards tumor progression. METHODS: Xenografts consisting of co-implanted human colorectal cancer cells with rat MSCs in immunodeficient mice were evaluated by tumor progression, angiogenic profiles, and MSC fate. Furthermore, we investigated how MSCs function as a cancer cell niche by co-culture experiments in vitro. RESULTS: Tumor growth progressed in two ways, either independent of or dependent on MSCs. Such cell line-specific dependency could not be explained by host immune competency. COLO 320 xenograft angiogenesis was MSC-dependent, but less dependent on vascular endothelial growth factor (VEGF), whereas HT-29 angiogenesis was not MSC-dependent, but was VEGF-dependent. MSCs and COLO 320 cells established a functional positive feedback loop that triggered formation of a cancer cell niche, leading to AKT activation. Subsequently, MSCs differentiated into pericytes that enhanced angiogenesis as a perivascular niche. In contrast, the MSC niche conferred an anti-proliferative property to HT-29 cells, through mesenchymal-epithelial transition resulting in p38 activation. CONCLUSIONS: In conclusion, MSCs demonstrate pleiotropic capabilities as a cancer cell or perivascular niche to modulate colorectal cancer cell fate in a cell line-dependent manner in a xenogeneic context.


Subject(s)
Colorectal Neoplasms/pathology , Mesenchymal Stem Cells/pathology , Neovascularization, Pathologic/pathology , Signal Transduction/physiology , Stem Cell Niche/physiology , Animals , Apoptosis , Blotting, Western , Cell Line, Tumor , Cell Proliferation , Coculture Techniques , Disease Models, Animal , Disease Progression , Heterografts , Humans , In Situ Hybridization, Fluorescence , Mice , Microarray Analysis , Neoplastic Processes , Rats , Real-Time Polymerase Chain Reaction , Transplantation, Heterologous
12.
Mod Rheumatol ; 25(3): 484-6, 2015 May.
Article in English | MEDLINE | ID: mdl-25180614

ABSTRACT

IgG4-related disease (IgG4-RD) is a new disease entity characterized by type 2 helper T (Th2)-dominant inflammation and progressive fibrosis. We found the infiltration of strange cell populations in the fibrotic lesions of submandibular gland specimens obtained from 15 patients with IgG4-RD. These cells expressed CCAAT/enhancer binding protein a (C/EBPα). Many of the cell populations were identified with M2 macrophages. The degrees of infiltration of C/EBPα(+)M2 macrophages and the ratio of fibrotic lesions in the specimens were correlated (r(2) = 0.83, p < 0.01). We also analyzed the expression of C/EBPα in other chronic inflammatory disorders: synovium in rheumatoid arthritis (RA), liver tissue in chronic viral hepatitis, and mucosa in ulcerative colitis. The specimens from RA and chronic viral hepatitis showed infiltration of C/EBPα(+) cells, but there were few C/EBPα-positive cells in ulcerative colitis. Fibrosis is not a major issue in ulcerative colitis. In conclusion, we found the remarkable infiltration of C/EBPα(+)M2 macrophages in cases of chronic inflammation with fibrosis, including IgG4-RD. This primitive study also disclosed that most of C/EBPα(+)M2 macrophages localized in fibrotic lesions, and the degree of the infiltration and the ratio of fibrotic area were correlated.


Subject(s)
Autoimmune Diseases/metabolism , CCAAT-Enhancer-Binding Protein-alpha/metabolism , Fibrosis/metabolism , Macrophages/metabolism , Aged , Autoimmune Diseases/pathology , Female , Fibrosis/pathology , Humans , Immunoglobulin G , Macrophages/pathology , Male , Middle Aged , Submandibular Gland/metabolism , Submandibular Gland/pathology
13.
Rheumatology (Oxford) ; 54(1): 45-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24907151

ABSTRACT

OBJECTIVES: Inducting clinical remission by glucocorticoid treatment is relatively easy in IgG4-related disease (IgG4-RD), but relapse also occurs easily with tapering of the steroid dose. The present study tried to analyse the cases to extract predictors of relapse present at the diagnosis of IgG4-RD. METHODS: Subjects comprised 79 patients with IgG4-related dacryoadenitis and sialadenitis, known as Mikulicz's disease, who were diagnosed between April 1997 and October 2013 and followed-up for >2 years from the initial induction treatment. They were applied to Cox proportional hazard modelling, based on the outcome of interval to relapse. We performed multivariate analysis for the clinical factors of these cases and identified predictors of relapse. RESULTS: Identified factors were male sex and younger onset in cases without organ involvement at diagnosis and low levels of serum IgG4 in cases with organ dysfunction at diagnosis. Complication with autoimmune pancreatitis and low steroid dose at initial treatment also tended to be associated with recurrence. CONCLUSION: Follow-up is important in cases with recognized risk factors for relapse, including male sex and younger onset in cases without organ damage.


Subject(s)
Age Factors , Glucocorticoids/therapeutic use , Immunoglobulin G/blood , Mikulicz' Disease/drug therapy , Mikulicz' Disease/epidemiology , Prednisolone/therapeutic use , Sex Factors , Adult , Age of Onset , Aged , Autoimmune Diseases/complications , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mikulicz' Disease/immunology , Multivariate Analysis , Pancreatitis/complications , Predictive Value of Tests , Proportional Hazards Models , Recurrence , Risk Factors , Treatment Outcome
14.
Mod Rheumatol ; 25(2): 199-204, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25159154

ABSTRACT

Abstract Objective. Immunoglobulin (Ig)G4-related disease (IgG4-RD) is a new disease entity that has only been identified this century. Clinical information is thus lacking. We established the Sapporo Medical University and Related Institutes Database for Investigation and Best Treatments of IgG4-related Disease (SMART) to clarify the clinical features of IgG4-RD and provide useful information for clinicians. Methods. Participants comprised 122 patients with IgG4-related dacryoadenitis and/or sialadenitis (IgG4-DS), representing lacrimal and/or salivary lesions of IgG4-RD, followed-up in December 2013. We analyzed the sex ratio, mean age at onset, organ dysfunction, history or complications of malignancy, treatments, rate of clinical remission, and relapse. Results. The sex ratio was roughly equal. Mean age at diagnosis was 59.0 years. Positron emission tomography revealed that the ratio of other organ involvements was 61.4%. Complications of malignancy were observed in 7.4% of cases. Glucocorticoid was used to treat 92.1% of cases, and the mean maintenance dose of prednisolone was 4.8 mg/day. Rituximab was added in three cases, and showed good steroid-sparing effect. The clinical remission rate was 73.8%, and the annual relapse rate was 11.5%. Half of the cases experienced relapses within 7 years of initial treatment. Conclusion. We analyzed the clinical features and treatments of IgG4-DS using SMART, providing useful information for everyday clinical practice.


Subject(s)
Autoimmune Diseases/diagnosis , Dacryocystitis/diagnosis , Immunoglobulin G , Immunosuppressive Agents/therapeutic use , Sialadenitis/diagnosis , Adult , Age of Onset , Aged , Aged, 80 and over , Autoimmune Diseases/drug therapy , Dacryocystitis/drug therapy , Databases, Factual , Female , Glucocorticoids/therapeutic use , Humans , Male , Middle Aged , Prednisolone/therapeutic use , Sialadenitis/drug therapy , Treatment Outcome , Young Adult
15.
Article in Japanese | MEDLINE | ID: mdl-24835137

ABSTRACT

A 73-year-old man with inflammatory abdominal aortic aneurysm was admitted with headache and fever. Chest computed tomography (CT) revealed pneumonia and antibiotic therapy was started. Short-term memory impairment was observed and his consciousness had been rapidly deteriorated with seazure. Fluid-attenuated inversion recovery (FLAIR) image and diffusion-weighted magnetic resonance image (DWI) showed high intensity signals around bilateral limbic areas and herpes simplex encephalitis was suspected. After human herpesvirus (HHV)-6 DNA was amplified from cerebrospinal fluid, he was diagnosed with HHV-6 encephalitis and treated with gancyclovir. Clinicians need to be aware that glucocorticoid treatment for elderly can cause HHV-6 encephalitis.


Subject(s)
Aortic Aneurysm, Abdominal/drug therapy , Encephalitis, Viral/etiology , Glucocorticoids/adverse effects , Herpesvirus 6, Human , Prednisolone/adverse effects , Roseolovirus Infections/etiology , Aged , Humans , Male
16.
Stem Cells ; 32(4): 913-25, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24715689

ABSTRACT

The role of mesenchymal stem cells (MSCs) in tumorigenesis remains controversial. Therefore, our goal was to determine whether exogenous MSCs possess intrinsic antineoplastic or proneoplastic properties in azoxymethane (AOM)-induced carcinogenesis. Three in vivo models were studied: an AOM/dextran sulfate sodium colitis-associated carcinoma model, an aberrant crypt foci model, and a model to assess the acute apoptotic response of a genotoxic carcinogen (AARGC). We also performed in vitro coculture experiments. As a result, we found that MSCs partially canceled AOM-induced tumor initiation but not tumor promotion. Moreover, MSCs inhibited the AARGC in colonic epithelial cells because of the removal of O(6)-methylguanine (O(6) MeG) adducts through O(6) MeG-DNA methyltransferase activation. Furthermore, MSCs broadly affected the cell-cycle machinery, potentially leading to G1 arrest in vivo. Coculture of IEC-6 rat intestinal cells with MSCs not only arrested the cell cycle at the G1 phase, but also induced apoptosis. The anti-carcinogenetic properties of MSCs in vitro required transforming growth factor (TGF)-ß signaling because such properties were completely abrogated by absorption of TGF-ß under indirect coculture conditions. MSCs inhibited AOM-induced tumor initiation by preventing the initiating cells from sustaining DNA insults and subsequently inducing G1 arrest in the initiated cells that escaped from the AARGC. Furthermore, tumor initiation perturbed by MSCs might potentially dysregulate WNT and TGF-ß-Smad signaling pathways in subsequent tumorigenesis. Obtaining a better understanding of MSC functions in colon carcinogenesis is essential before commencing the broader clinical application of promising MSC-based therapies for cancer-prone patients with inflammatory bowel disease.


Subject(s)
Azoxymethane/toxicity , Carcinogens/toxicity , Colonic Neoplasms/metabolism , Mesenchymal Stem Cells/metabolism , Neoplasms, Experimental/metabolism , Animals , Cells, Cultured , Coculture Techniques , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , G1 Phase Cell Cycle Checkpoints/drug effects , Humans , Mesenchymal Stem Cells/pathology , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/pathology , Rats , Rats, Inbred Lew , Transforming Growth Factor beta/metabolism , Wnt Signaling Pathway/drug effects
17.
Mod Rheumatol ; 24(6): 953-60, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24593171

ABSTRACT

OBJECTIVES: Immunoglobulin (Ig) G4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease (MD), is a chronic inflammatory disease. However, little is known about its pathogenesis and pathological condition. In the present study, we used immunohistological techniques to compare the roles of cytotoxic T lymphocytes (CTLs) in MD and primary Sjogren's syndrome (SS). We examined the state of CTLs [cytotoxic granule-positive rate and programmed death-1 (PD-1) expression rate] in the salivary glands. METHODS: The study samples comprised 12 submaxillary glands from untreated MD patients and 12 labial glands from SS patients. We performed immunofluorescence and multicolor immunofluorescence to stain CD8, perforin (PRF), granzyme B (GZMB), and PD-1. We measured the total number of CTLs as well as the PRF(+)CTLs, GZMB(+)CTLs, and PD-1(+)CTLs. RESULTS: We found that the degree of infiltration of CTLs was equal in MD and SS, but the rate of CTLs with cytotoxic granules, especially PRF, in MD was less than in SS. In addition, the frequency of PD-1(+)CTLs in MD was higher than that in SS. CONCLUSIONS: Cytotoxic granule-positive CTLs were in the minority in D salivary glands, and this regulation might relate to PD-1 signals like the state of exhaustion and anergy.


Subject(s)
Dacryocystitis/immunology , Immunoglobulin G , Mikulicz' Disease/immunology , Sialadenitis/immunology , T-Lymphocytes, Cytotoxic/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Dacryocystitis/pathology , Female , Humans , Male , Middle Aged , Mikulicz' Disease/pathology , Salivary Glands/immunology , Salivary Glands/pathology , Sialadenitis/pathology , Sjogren's Syndrome/immunology , Sjogren's Syndrome/pathology , T-Lymphocytes, Cytotoxic/pathology
18.
J Gastroenterol ; 49(2): 270-82, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24217964

ABSTRACT

BACKGROUND: Although mounting evidence implicates mesenchymal stem cells (MSCs) in intestinal tissue repair, controversy remains regarding the engraftment, proliferation, and differentiation for repopulating MSCs in recipient tissues. Therefore, we investigated the paracrine and/or endocrine role of MSCs in experimental colitis. METHODS: We analyzed the therapeutic effects of MSC-conditioned medium (MSC-CM) on dextran sulfate sodium (DSS)- or 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. We investigated the effects of MSC-CM on the epithelial cell viability, mobility, cell cycle, and cytokine production in ex vivo lamina propria/mesenteric lymphocytes, a macrophage cell line, and the mixed lymphocyte reaction. An optimal regimen against colitis was explored. The contents of MSC-CM were analyzed using a WNT signaling pathway polymerase chain reaction array, an inflammatory cytokines antibody array, and liquid chromatography-tandem mass spectrometry analysis. RESULTS: Independent of the systemic administration route, MSC-CM concentrates were effective for the inductive phase of TNBS-induced colitis and for the recovery phase of DSS-induced colitis. Hypoxia appeared to be one of the optimal preconditioning factors assessed by cell motility and viability through activating the PI3K-Akt pathway in rat small intestine epithelial cells, IEC-6. Thus, Hypoxia had profound effects on the contents of MSC-CM, which comprised pleiotropic gut trophic factors involved in each wound healing process, including the anti-inflammatory, proliferative, and tissue remodeling phases. CONCLUSIONS: Identification and optimization of potential gut trophic factors in MSC-CM is urgently needed to form the basis for new drug discovery and for optimizing cell-based therapies for inflammatory bowel disease.


Subject(s)
Colitis/drug therapy , Culture Media, Conditioned/pharmacology , Cytokines/metabolism , Mesenchymal Stem Cells/metabolism , Animals , Apoptosis , Caco-2 Cells , Cell Cycle/drug effects , Cell Hypoxia , Cell Movement/drug effects , Cell Survival/drug effects , Chemokine CCL2/analysis , Colitis/chemically induced , Colitis/pathology , Culture Media, Conditioned/chemistry , Cytokines/analysis , Dextran Sulfate , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelial Cells/physiology , Humans , Intercellular Signaling Peptides and Proteins/genetics , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Lymphocytes/drug effects , Lymphocytes/metabolism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Membrane Proteins/genetics , Mice , Oligonucleotide Array Sequence Analysis , Protein Array Analysis , Proto-Oncogene Proteins/genetics , Rats , Rats, Inbred Lew , Rats, Wistar , Trinitrobenzenesulfonic Acid , Up-Regulation/drug effects , Vascular Endothelial Growth Factor A/analysis , Wnt Proteins/genetics , Wnt Signaling Pathway/genetics
20.
Rheumatology (Oxford) ; 52(4): 679-83, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23258649

ABSTRACT

OBJECTIVE: Despite ongoing research, the clinical and histopathological natural history of immunoglobulin (Ig) G4-related disease (IgG4-RD) remains unclear and the optimal time to initiate treatment is unknown. A focus on clinical symptoms rather than image finding is recommended for therapeutic initiation in autoimmune pancreatitis, but evidence for this approach is lacking. We aimed to retrospectively analyse disease duration, efficacy of treatment with glucocorticoids and results of histopathological examination of submandibular gland specimens to clarify the necessity for early intervention in IgG4-RD. METHODS: Salivary secretions were assessed before and after treatment in 26 cases of IgG4-related Mikulicz's disease (IgG4-MD). Relationships between disease duration, amount of salivary secretion before treatment, improvement of salivary secretion and ratios of areas of residual acini, fibrosis and lymphoid follicles in the involved submandibular gland specimens were analysed. RESULTS: Salivary secretions were significantly reduced in cases with illness of >2 years (P < 0.05). An inverse correlation was seen between improved amount of salivary secretion and amount of salivary secretion before treatment (r = -0.60). Improved amount of salivary secretion was also associated with each histological factor (acini, r = 0.29; fibrosis, r = -0.23; lymphoid follicles, r = -0.31), which showed interrelationships (acini and lymphoid follicles, r = -0.23; acini and fibrosis, r = 0.42; lymphoid follicles and fibrosis, r = 0.30). CONCLUSION: Salivary secretion can be improved even in cases with lower levels of salivary secretion before treatment in IgG4-RD, but improvements in the amount of salivary secretion decrease with histological changes with delayed therapeutic intervention. These data suggest that early intervention is needed to improve outcomes in patients with IgG4-MD.


Subject(s)
Glucocorticoids/therapeutic use , Immunoglobulin G/blood , Mikulicz' Disease/drug therapy , Prednisolone/therapeutic use , Submandibular Gland/pathology , Aged , Disease Progression , Early Medical Intervention , Female , Fibrosis , Humans , Male , Middle Aged , Mikulicz' Disease/immunology , Mikulicz' Disease/pathology , Retrospective Studies , Saliva/metabolism , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL